C12Y 114/13132
Squalene monooxygenase
Official title: Squalene monooxygenase (1.14.13.132)
C12Y114/13132 (Squalene monooxygenase) appears on 10 US grants and 14 published applications in this corpus.
Search patents in C12Y- Granted patents
- 10
- Published applications
- 14
- Assignees
- 9
- Inventors
- 30
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 3 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 2 | 2 |
| 2019 | 3 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Production of lipids and terpenoids in Auxenochlorella protothecoides5 May 2026US 12,618,088 B2Phycoil Biotechnology International, Inc.
- Production of lipids and terpenoids in Auxenochlorella protothecoides16 Jul 2024US 12,037,630 B2Phycoil Biotechnology International, Inc.
- Squalene epoxidase in the diagnosis and treatment of non-alcoholic fatty liver diseases24 May 2022US 11,340,226 B2The Chinese University of Hong Kong
- Methods and materials for biosynthesis of mogroside compounds26 May 2020US 10,662,458 B2Evolva SA
- Methods and materials for biosynthesis of mogroside compounds5 Nov 2019US 10,465,222 B2Evolva SA
- Mogroside compositions and methods of producing same18 Sep 2025US 2025/0290110 A1
- Production of Lipids and Terpenoids in Auxenochlorella Protothecoides7 Nov 2024US 2024/0368646 A1Phycoil Biotechnology International, Inc.
- Production of lipids and terpenoids in auxenochlorella protothecoides19 May 2022US 2022/0154229 A1Phycoil Biotechnology International, Inc.
- Squalene epoxidase in the diagnosis and treatment of non-alcoholic fatty liver diseases5 Sep 2019US 2019/0271698 A1The Chinese University of Hong Kong
- Methods and materials for Biosynthesis of Mogroside Compounds6 Dec 2018US 2018/0346953 A1Evolva SA
Most cited
By later US patents
- Methods and materials for biosynthesis of mogroside compounds9US 10,011,859 B2Evolva SA · 2018
- Method for the production of 7-dehydrocholesterol and/or the biosynthetic intermediate or subsequent products thereof in transgenic organisms5US 7,608,421 B2Organobalance GmbH · 2009
- Methods and materials for biosynthesis of mogroside compounds4US 9,932,619 B2Evolva SA · 2018
- Methods and materials for biosynthesis of mogroside compounds1US 10,465,222 B2Evolva SA · 2019
- Methods and materials for biosynthesis of mogroside compounds1US 10,662,458 B2Evolva SA · 2020